Double-blind, Randomised Study of A3384 in BAM/BAD
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the efficacy and safety of A3384 administered to
patients with Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD).